SlowBull
The Business Brief TUESDAY, 8 SEPTEMBER 2026
← All stories
Markets

Pulmovant’s mosliciguat meets phase 2 trial endpoints in PH-ILD

1 source ·2 articles ·1h ago

Covered by 1 outlet

Investing 2

All coverage · 2 articles

Investing.com Canada ·1h ago

Pulmovant’s mosliciguat meets phase 2 trial endpoints in PH-ILD

Investing.com News ·1h ago

Pulmovant’s mosliciguat meets phase 2 trial endpoints in PH-ILD